Zargis Cardioscan(TM) Featured on The Early Show on CBS
STAMFORD, Conn., Nov. 24 /PRNewswire/ — Zargis Medical Corp., a subsidiary of Speedus Corp. (Nasdaq: SPDE) and a spin-off from Siemens Corporate Research (NYSE: SI), today announced that its Zargis Cardioscan device was featured on the November 24, 2009 episode of CBS’ The Early Show during a segment in which Mark Jannot, the editor of Popular Science magazine, reviewed five winning products from the publication’s 2009 “Best of What’s New” awards.
The Early Show is a widely-viewed television morning news talk show broadcast by CBS from New York City Monday through Saturday. A video clip of the “Best of What’s New” awards segment can be viewed via the following link: http://tinyurl.com/Zargis-on-CBS.
As previously announced, 3M(TM) Health Care and Zargis Medical were jointly awarded “Innovation of the Year” by Popular Science for Zargis Cardioscan and the compatible 3M(TM) LittmannÃ‚® Electronic Stethoscope Model 3200. During the segment on The Early Show, Mark Jannot described Cardioscan and the Model 3200 stethoscope as follows: “[It's] the same thing that you see around your doctor’s neck every time you go to the doctor’s office, but it’s our Innovation of the Year because it’s a really revolutionary diagnostic device. It sends your heart sounds by BluetoothÃ‚® to a nearby computer where software will analyze it to detect hard-to-find heart murmurs.”
According to Peter Hodge, Zargis’ marketing director, “We are very encouraged by the level of interest Zargis Cardioscan is receiving in the both the healthcare arena and the mainstream media, especially as we prepare for the international roll-out of the device.”
About Zargis Cardioscan
Zargis Cardioscan is the first and only computer-assisted medical device designed to support physicians in analyzing heart sounds for the identification of suspected systolic and diastolic murmurs. Cardioscan is a non-invasive device that is easy to use, portable, and takes just minutes to perform. The device implements voice-guided protocol and a graphical user interface while maintaining an efficient physician workflow. Cardioscan provides a summary of findings in terms that are readily understood by physicians and offers an additional range of quantitative auscultatory information that cannot be obtained through listening alone. Cardioscan is intended to enhance auscultation — a procedure that has been universally employed through a stethoscope for nearly two-hundred years.
About Zargis Medical Corp.
Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE: SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds. Zargis and 3M(TM) (NYSE: MMM) jointly launched Cardioscan and the Model 3200 stethoscope in August 2009 as part of an exclusive global multi-year global marketing alliance.
Statements contained herein that are not historical facts, including but not limited to statements about the Company’s product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company’s sales, marketing and support efforts.
SOURCE Zargis Medical Corp.